Literature DB >> 19894009

Botulinum toxin type A in the healing of a chronic buttock ulcer in a patient with spastic paraplegia after spinal cord injury.

Domenico Intiso1, Mario Basciani.   

Abstract

BACKGROUND: Pressure sores are a significant secondary complication in spinal cord injured patients. A new indication for botulinum toxin type A is described here, in treatment of recurrent muscular spasms that had hampered the healing of a chronic buttock ulcer in a subject with severe spastic paraplegia. CASE REPORT: A 27-year-old man with spastic paraplegia following traumatic spinal cord lesion at the thoracic level had developed recurrent severe muscular spasms, particularly involving the buttock region, with an Ashworth scale score of 3-4 and a Spasm Frequency Scale of grade 4. The patient had a pressure ulcer in the left gluteal region (grade IV according to the European Pressure Ulcer Advisory Panel (EPUAP). Several treatments were administered without success, and all efforts at healing the ulcer by topical medication were hampered by recurrent spasms involving the buttock muscles and ulcer region. The left gluteus maximus muscle was treated with 2 infiltrations of 660 IU botulinum toxin type A. The use of botulinum toxin type A allowed better care of the pressure ulcer, which had healed by 6 months after the initial infiltration.
CONCLUSION: The use of botulinum toxin type A may be an important adjunctive therapy for treatment of pathological conditions involving recalcitrant involuntary muscle contraction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19894009     DOI: 10.2340/16501977-0460

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  9 in total

Review 1.  Chemodenervation for treatment of limb spasticity following spinal cord injury: a systematic review.

Authors:  J Lui; M Sarai; P B Mills
Journal:  Spinal Cord       Date:  2015-01-13       Impact factor: 2.772

2.  Botulinum toxin type A in the healing of chronic lesion following bilateral spasticity of gluteus muscle.

Authors:  Emanuele Cigna; Michele Maruccia; Benedetta Fanelli; Nicolò Scuderi
Journal:  Int Wound J       Date:  2012-10-19       Impact factor: 3.315

3.  Treatment of spasticity in spinal cord injury with botulinum toxin.

Authors:  Ramiro Palazón-García; Mónica Alcobendas-Maestro; Ana Esclarin-de Ruz; Ana María Benavente-Valdepeñas
Journal:  J Spinal Cord Med       Date:  2018-06-05       Impact factor: 1.985

4.  Therapeutic use of botulinum toxin in neurorehabilitation.

Authors:  Domenico Intiso
Journal:  J Toxicol       Date:  2011-09-14

5.  Kinetic and reaction pathway analysis in the application of botulinum toxin a for wound healing.

Authors:  Frank J Lebeda; Zygmunt F Dembek; Michael Adler
Journal:  J Toxicol       Date:  2011-11-24

Review 6.  Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation.

Authors:  Domenico Intiso; Mario Basciani; Andrea Santamato; Marta Intiso; Filomena Di Rienzo
Journal:  Toxins (Basel)       Date:  2015-06-30       Impact factor: 4.546

Review 7.  Botulinum Toxin Type A for the Treatment of Skin Ulcers: A Review Article.

Authors:  Waranaree Winayanuwattikun; Vasanop Vachiramon
Journal:  Toxins (Basel)       Date:  2022-06-14       Impact factor: 5.075

8.  Antispastic therapy with botulinum toxin type A in patients with traumatic spinal cord lesion.

Authors:  Ulrich J Spiegl; Doris Maier; Oliver Gonschorek; Christoph-Eckhard Heyde; Volker Bühren
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2014-12-10

9.  Can Botulinum Toxin Type A effectively treat neuropathic pain in spinal cord injury?: A protocol of systematic review and meta-analysis.

Authors:  Zeng-Mian Wang; Ze-Yu Wang; Chun-Jie Wei; Yao-Jia Jiang
Journal:  Medicine (Baltimore)       Date:  2020-06-19       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.